CF Industries
CF
$120.85
+0.90%
CF Industries is a leading global producer and distributor of nitrogen-based products, primarily ammonia, granular urea, UAN (urea ammonium nitrate), and ammonium nitrate, which serve agricultural fertilizer markets alongside industrial applications. The company operates large-scale nitrogen manufacturing complexes in North America and the United Kingdom, plus a joint venture in Trinidad and Tobago, and its competitive identity rests on being one of the world's lowest-cost producers thanks to cheap US natural gas feedstock — a structural cost moat that lets it out-earn higher-cost peers through the commodity cycle. The current investor narrative has been dominated by the 2026 Strait of Hormuz disruption, which stranded a large share of global fertilizer supply and handed North American producers a windfall margin opportunity, driving record quarterly results and a sharp re-rating of the stock. That tailwind is now colliding with de-escalation headlines (Hormuz reopening, oil crashing on truce hopes), so the debate has shifted to how much of the elevated pricing environment is durable versus cyclical, and whether CF's blue/green ammonia investments can extend the growth runway beyond the fertilizer cycle.…
CF
CF Industries
$120.85
Investment Opinion: Should I buy CF Today?
Rating: Hold. CF's low-cost producer position and robust cash flow generation are attractive, but the stock appears fairly valued after a 45% one-year rally, with the analyst consensus hold and average target of $127.69 offering only 5.7% upside. The core thesis is that current earnings are near a cyclical peak, and the market is unlikely to award a higher multiple until nitrogen price durability is proven.
Supporting evidence: CF trades at 8.61x trailing PE and 4.41x EV/EBITDA, below the Basic Materials sector average, yet its 30.1% ROE and 20.5% net margin are superior. Revenue grew 17.57% YoY in Q2 2026 to $2.22 billion, and free cash flow of $1.91 billion provides a 15.2% FCF yield. The 2.6% dividend yield and low 22.4% payout ratio suggest ample room for continued buybacks. However, the forward PE of 10.83x exceeding the trailing PE signals expected earnings decline, and the PEG ratio of 0.26 is based on peak earnings.
Risks and conditions: The biggest risks are a faster-than-expected normalization of nitrogen prices as geopolitical tensions ease, and a potential margin compression that could cut EPS by half. This Hold would upgrade to Buy if the stock pulls back to the $105 analyst low (13% downside) or if nitrogen prices show structural staying power beyond 2026. It would downgrade to Sell if Q3 earnings miss and gross margins fall below 40%, or if the Hormuz reopening leads to a sustained glut. Valuation verdict: fairly valued relative to history and peers, with limited margin of safety at current levels.
Sign up to view all
CF 12-Month Price Forecast
CF presents a balanced risk/reward: the stock is cheap on current earnings but expensive on forward earnings, and the market is pricing in a normalization of nitrogen prices. The low-cost producer advantage and strong cash flow generation limit downside, but the lack of near-term catalysts and hold consensus cap upside. We would upgrade to bullish if nitrogen prices prove stickier than expected (e.g., gross margins hold above 45% for two more quarters) or if the stock pulls back to the $105 area. We would downgrade to bearish if Q3 earnings miss and margins compress below 40%, or if geopolitical de-escalation accelerates.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CF Industries's 12-month outlook, with a consensus price target around $127.69 and implied upside of +5.7% versus the current price.
Average Target
$127.69
0 analysts
Implied Upside
+5.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$105 - $196
Analyst target range
Coverage is broad with 20 analysts, but sentiment is decidedly lukewarm: the consensus recommendation is "hold" with a mean rating of 2.82 (where 1 is strong buy and 5 is strong sell), and the average target price of $127.69 implies just +5.7% upside from the current $120.85. That modest upside, combined with the hold consensus, suggests the Street views the stock as fairly valued after its big run and is waiting for clarity on nitrogen price durability before turning more constructive.
The target range is extremely wide — from a low of $105 (about -13.1% downside) to a high of $195.72 (roughly +62% upside) — signaling high uncertainty about the cycle. The high target likely assumes sustained Hormuz-driven supply tightness, elevated nitrogen realizations, and multiple expansion on peak earnings, while the low target prices in a normalization of fertilizer prices as geopolitical risk unwinds and margins compress toward mid-cycle levels. Recent institutional actions skew cautious-to-mixed: Rothschild upgraded to Neutral from Sell in late September, Scotiabank moved to Sector Outperform in June, but UBS, RBC, Morgan Stanley, JP Morgan, and CIBC all sit at Neutral/Equal Weight/Sector Perform, and Barclays is the notable Overweight — a distribution that reinforces the "hold" consensus and the view that the easy money in this cyclical upswing has already been made.
Bulls vs Bears: CF Investment Factors
The bull case rests on CF's structural cost advantage, exceptional cash flow generation, and undemanding valuation, which provide a margin of safety even if nitrogen prices moderate. However, the bear case is equally compelling: earnings are at cyclical peaks, the geopolitical supply shock is unwinding, and the analyst consensus is a lukewarm hold with only 5.7% upside to the average target. The most important tension is the durability of elevated nitrogen prices—if they hold, the stock is cheap; if they normalize, earnings could halve. Currently, the bear evidence slightly outweighs the bull due to the forward PE exceeding trailing PE and negative relative strength, but the strong balance sheet and FCF yield limit downside.
Bullish
- Low-cost producer moat: CF's access to cheap US natural gas feedstock underpins a structural cost advantage, evidenced by a Q2 2026 gross margin of 51.5% and operating margin of 47.3%, well above the trailing 38.5% and 33.4% respectively. This cost moat allows CF to generate superior margins even when nitrogen prices normalize, providing a cushion against cyclical downturns.
- Cash flow gusher and capital returns: Trailing free cash flow of $1.91 billion against a $12.5 billion market cap implies an FCF yield of roughly 15.2%, among the highest in the sector. In Q2 alone, operating cash flow of $878 million funded $271 million of capex and $225 million of buybacks plus $77 million of dividends, highlighting robust cash generation and shareholder-friendly capital allocation.
- Valuation still undemanding: At 8.61x trailing PE and 4.41x EV/EBITDA, CF trades at a discount to the broader Basic Materials sector, despite a 30.1% ROE and 20.5% net margin. The 2.6% dividend yield and 15%+ FCF yield provide a margin of safety, and the PEG ratio of 0.26 suggests the stock is cheap relative to expected earnings growth.
- Strong technical uptrend: CF is up 45.57% over the past year and 50.82% YTD, significantly outpacing the S&P 500's 15.53% and 11.93% gains. The stock recently bounced 8.3% off the October low of $111.54, defending key support, and a breakout above the 52-week high of $141.96 could trigger a new leg higher.
Bearish
- Peak-cycle earnings risk: The forward PE of 10.83x exceeds the trailing PE of 8.61x, implying the market expects earnings to decline from current cyclical highs. Q2 2026 EPS of $4.74 may not be sustainable as nitrogen prices normalize, and the PEG ratio of 0.26 is based on peak earnings, which could reverse.
- Geopolitical premium unwinding: The Strait of Hormuz reopening and Iran truce hopes have already triggered a 14% crash in oil and a rotation out of fertilizer winners. CF's relative strength versus SPY is -9.66 over 1 month and -3.16 over 3 months, reflecting this de-risking, and further de-escalation could remove the supply-shock tailwind entirely.
- Hold consensus and limited upside: With a consensus rating of 2.82 (hold) and an average target of $127.69, implying only 5.7% upside, the Street sees limited near-term appreciation. Major firms like UBS, RBC, Morgan Stanley, JP Morgan, and CIBC are all Neutral/Equal Weight, suggesting the easy money has been made.
- Margin normalization ahead: Q2 2026 gross margin of 51.5% and net margin of 32.7% are likely peak levels; historical quarterly gross margins have ranged from 32.5% to 44.8% in 2024-2025. As nitrogen prices revert, margins could compress toward the 38.5% trailing gross margin, pressuring earnings.
CF Technical Analysis
CF is in a powerful primary uptrend, with the stock up 45.57% over the past year and 50.82% year-to-date, dramatically outpacing the S&P 500's 15.53% and 11.93% respective gains. At $120.85, the stock sits at roughly 67.9% of its 52-week range of $75.42 to $141.96 — comfortably in the upper half but not pinned to the highs, which suggests a healthy trend that has already digested a meaningful pullback rather than an overextended blow-off top. The 52-week high of $141.96 was set in early September, and the current price is about 14.9% below that peak, so the stock is consolidating its gains rather than breaking down.
Short-term momentum has clearly decelerated and diverged from the longer-term trend: the stock is down 8.44% over the past month and essentially flat over three months (-0.47%), even as the 1-year gain remains a robust 45.57%. This divergence is confirmed by relative strength figures — relative strength versus SPY is -9.66 over 1 month and -3.16 over 3 months, yet still +30.04 over 1 year — signaling that the market has been rotating out of the fertilizer/commodity winners as geopolitical risk premiums unwind. The recent bounce from the October 9 low of $111.54 back to $120.85 (+8.3% in five sessions) suggests buyers are defending the $110-115 zone, but the inability to reclaim the September highs keeps the near-term bias neutral-to-cautious.
Key technical levels are well defined: support sits at the October swing low of $111.54 and, more structurally, the 52-week low of $75.42, while resistance is the 52-week high of $141.96. A breakout above $142 would confirm trend re-acceleration and likely open a new leg higher, whereas a breakdown below $111 would signal that the post-Hormuz windfall is fully priced and put the $100 area in play. Volatility is unusually low for a commodity producer — beta of just 0.527 means the stock moves roughly half as much as the market, which supports larger position sizing for risk-budgeted portfolios but also means the stock's 25.75% max drawdown reflects idiosyncratic commodity/geopolitical risk rather than broad market beta.
Beta
0.53
0.53x market volatility
Max Drawdown
-25.8%
Largest decline past year
52-Week Range
$75-$142
Price range past year
Annual Return
+45.6%
Cumulative gain past year
| Period | CF Return | S&P 500 |
|---|---|---|
| 1m | -8.4% | +0.2% |
| 3m | -0.5% | +2.9% |
| 6m | +7.3% | +8.4% |
| 1y | +45.6% | +14.9% |
| ytd | +50.8% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CF Fundamental Analysis
CF's revenue trajectory is clearly re-accelerating: Q2 2026 revenue hit $2.222 billion, up 17.57% year-over-year versus $1.890 billion in Q2 2025, and the sequential climb from $1.986 billion in Q1 2026 and $1.872 billion in Q4 2025 confirms a strengthening top line. The segment mix shows granular urea ($759 million) and UAN ($613 million) as the largest contributors, with ammonia at $586 million and AN at just $75 million, meaning the nitrogen complex is firing on nearly all cylinders as Hormuz-driven supply tightness lifted realizations. This growth is fundamentally supply-shock-driven rather than volume-led, so the investment case hinges on how long elevated nitrogen prices persist — a key risk given the recent de-escalation headlines.
Profitability is exceptional for a commodity chemical producer: Q2 2026 net income reached $727 million on a 32.7% net margin, with gross margin of 51.5% and operating margin of 47.3%, both well above the 38.5% gross margin and 33.4% operating margin shown in the trailing valuation metrics. The margin trajectory is expanding sharply — gross margin rose from 37.6% in Q1 2026 to 51.5% in Q2, and net margin climbed from 31.0% to 32.7% — reflecting operating leverage on higher nitrogen prices against a low, stable natural gas cost base. ROE of 30.1% and ROA of 12.9% are strong absolute returns that validate the low-cost producer thesis, though investors should recognize these are cyclical peak-ish margins rather than a normalized run-rate.
Balance sheet and cash generation are solid: debt-to-equity of 0.82 is moderate, the current ratio of 3.37 signals ample liquidity, and trailing free cash flow of $1.91 billion against a $12.5 billion market cap implies an FCF yield of roughly 15.2% — a very attractive cash return. Q2 2026 operating cash flow of $878 million funded $271 million of capex and still left $607 million of free cash flow, while the company returned capital via $225 million of buybacks and $77 million of dividends. The main caveat is that working capital swings are large (a $233 million Q2 drag), and the 2.6% dividend yield with a low 22.4% payout ratio leaves room for continued buybacks, but the cash flow strength is clearly tied to the current elevated pricing environment.
Quarterly Revenue
$2.2B
2026-06
Revenue YoY Growth
+17.6%
YoY Comparison
Gross Margin
51.5%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CF Overvalued?
Because CF is solidly profitable (Q2 2026 net income of $727 million), the PE ratio is the appropriate primary metric. The stock trades at a trailing PE of just 8.61x versus a forward PE of 10.83x — notably, the forward multiple is higher than the trailing, which implies the market expects earnings to normalize lower from the current cyclical peak rather than grow, a classic signal that investors are treating today's profits as unsustainable. The PEG ratio of 0.26 and EV/EBITDA of 4.41x both point to a cheap-looking stock on current numbers, but that cheapness is largely a function of peak-cycle earnings.
Against the broader Basic Materials sector, CF's 8.61x trailing PE and 4.41x EV/EBITDA sit at the low end of the range for a commodity chemical producer, and its 1.77x PS ratio and 2.59x PB ratio are modest. The discount is arguably justified by the cyclicality of nitrogen pricing — the market is unwilling to capitalize windfall Hormuz-era margins at a full multiple — but the 38.5% gross margin, 20.5% net margin, and 30.1% ROE are well above typical industry profitability, suggesting the discount may be too deep if nitrogen prices prove stickier than feared. The 2.6% dividend yield and 15%+ FCF yield provide a valuation floor that most cyclical peers lack.
Historically, CF's PE has ranged widely — from roughly 3.8x in mid-2022 (peak earnings) to over 25x in late 2023 (trough earnings) — and the current 8.61x sits in the lower-middle of that band, consistent with a market that sees earnings near a cyclical high. The PS ratio of 1.77x is near the low end of its multi-year range (which has stretched from roughly 5x to 13x on quarterly snapshots), reinforcing that the stock is not expensive on sales even after its 45% one-year rally. The read-through is that valuation offers a margin of safety if the cycle holds, but offers limited multiple expansion upside unless the market becomes convinced the earnings base is structurally higher.
PE
8.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the sustainability of peak-cycle margins and cash flows. Q2 2026 gross margin of 51.5% and net margin of 32.7% are well above the trailing 38.5% and 20.5%, respectively, and a reversion to mid-cycle levels could cut earnings significantly. Additionally, working capital swings are large, with a $233 million Q2 drag, and debt-to-equity of 0.82 is moderate but manageable given a 3.37 current ratio. The company's revenue is concentrated in nitrogen products, with granular urea ($759M) and UAN ($613M) accounting for 61.7% of Q2 sales, exposing it to a single commodity cycle.
Market and competitive risks include valuation compression if nitrogen prices normalize and the market re-rates the stock lower. CF's beta of 0.527 indicates low correlation with the broader market, but its 25.75% max drawdown over the past year reflects idiosyncratic commodity and geopolitical risk. The recent de-escalation in the Middle East (Hormuz reopening, oil crashing 14%) has already pressured the stock, with relative strength versus SPY at -9.66 over one month. Competitive threats from lower-cost producers in Russia and the Middle East could intensify if sanctions ease, and regulatory risks around carbon emissions could raise operating costs for CF's blue/green ammonia initiatives.
Worst-case scenario: A full normalization of nitrogen prices as geopolitical risks subside, combined with a broader market rotation out of commodities, could drive CF down to its 52-week low of $75.42, representing a 37.6% decline from the current $120.85. The analyst low target of $105 implies a 13.1% downside, but historical drawdowns have been deeper. If earnings revert to 2024 levels (EPS ~$7.36) and the market applies a 10x multiple, the stock could trade near $73.60, close to the 52-week low. Investors could lose over 35% in this adverse scenario.
FAQ
The key risks are: 1) Commodity price risk—nitrogen prices could fall as geopolitical tensions ease, compressing margins from the current 51.5% gross margin toward the 38.5% trailing level. 2) Earnings cyclicality—Q2 2026 EPS of $4.74 may be a peak, and the forward PE exceeding trailing signals expected decline. 3) Geopolitical risk—the Strait of Hormuz reopening could remove the supply-shock premium, as already reflected in the -9.66 relative strength over one month. 4) Operational and regulatory risks—natural gas price spikes or carbon regulations could raise costs. The most severe is commodity price risk, which could drive the stock to the 52-week low of $75.42.
Our 12-month forecast has a base case (55% probability) of $115-130, aligned with the analyst average target of $127.69, assuming nitrogen prices moderate but remain above mid-cycle. The bull case (25% probability) targets $141.96-195.72 if supply disruptions persist and margins stay elevated. The bear case (20% probability) targets $75.42-105 if prices normalize rapidly. The most likely scenario is the base case, hinging on a gradual de-escalation of geopolitical risks and stable natural gas costs. Key catalysts include Q3 earnings and Hormuz developments.
CF appears fairly valued to slightly undervalued on trailing metrics but potentially overvalued on forward earnings. The trailing PE of 8.61x is below the sector average, and the 4.41x EV/EBITDA is low, suggesting the market is discounting peak earnings. However, the forward PE of 10.83x is higher than trailing, implying expected earnings decline. The PS ratio of 1.77x is near the low end of its historical range, and the 2.6% dividend yield is above the sector median. Overall, the market is pricing in a normalization of nitrogen prices, so the stock is not expensive if the cycle holds, but offers limited multiple expansion upside.
CF is a good buy only for investors with a value tilt and tolerance for commodity cyclicality. The stock trades at 8.61x trailing PE and offers a 15.2% FCF yield, which provides a margin of safety, but the analyst consensus is hold with only 5.7% upside to the average target. The biggest downside risk is a normalization of nitrogen prices, which could cut earnings by half and drive the stock toward the $105 analyst low (13% downside) or the 52-week low of $75.42 (37.6% downside). For long-term income-focused investors, the 2.6% dividend yield and buybacks are attractive, but near-term upside is limited.
CF is more suitable for medium-to-long-term investment (at least 2-3 years) to ride out commodity cycles, given its low beta of 0.527 and strong cash flow generation. Short-term trading is risky due to geopolitical headline sensitivity and recent negative momentum (-8.44% over one month). The dividend yield of 2.6% and consistent buybacks reward patient investors, but earnings visibility is low due to nitrogen price volatility. A minimum holding period of 2-3 years is recommended to capture a full cycle and benefit from capital returns.